Search

Your search keyword '"Agar, Nathalie Y. R."' showing total 266 results

Search Constraints

Start Over You searched for: Author "Agar, Nathalie Y. R." Remove constraint Author: "Agar, Nathalie Y. R."
266 results on '"Agar, Nathalie Y. R."'

Search Results

2. A non-dividing cell population with high pyruvate dehydrogenase kinase activity regulates metabolic heterogeneity and tumorigenesis in the intestine

3. Single cell spatial analysis reveals the topology of immunomodulatory purinergic signaling in glioblastoma

4. Spatial Profiling of Metals through Matrix-Assisted Laser Desorption Ionization Mass Spectrometry Imaging

5. Pilot trial of perampanel on peritumoral hyperexcitability and clinical outcomes in newly diagnosed high-grade glioma

7. Evaluating protein cross-linking as a therapeutic strategy to stabilize SOD1 variants in a mouse model of familial ALS

8. A unique subset of glycolytic tumour-propagating cells drives squamous cell carcinoma

11. The dentate gyrus differentially metabolizes glucose and alternative fuels during rest and stimulation.

12. Chemical QuantArray: A Quantitative Tool for Mass Spectrometry Imaging

16. DIPG-19. BAF COMPLEX PERTURBATION AS A NOVEL THERAPEUTIC OPPORTUNITY IN H3K27M PEDIATRIC GLIOMA

17. WSD-0922, a novel brain-penetrant inhibitor of EGFR, promotes survival in glioblastoma mouse models

21. Chronic convection-enhanced delivery of topotecan for patients with recurrent glioblastoma: a first-in-patient, single-centre, single-arm, phase 1b trial

23. Intraoperative mass spectrometry mapping of an onco-metabolite to guide brain tumor surgery

24. Integrated mapping of pharmacokinetics and pharmacodynamics in a patient-derived xenograft model of glioblastoma

25. Oncometabolite d -2HG alters T cell metabolism to impair CD8 + T cell function

29. Overcoming differential tumor penetration of BRAF inhibitors using computationally guided combination therapy

30. Multiplatform Metabolomics Studies of Human Cancers With NMR and Mass Spectrometry Imaging

32. Convection enhanced delivery of EGFR targeting antibody-drug conjugates Serclutamab talirine and Depatux-M in glioblastoma patient-derived xenografts

34. WSD-0922, a novel brain-penetrant inhibitor of epidermal growth factor receptor, promotes survival in glioblastoma mouse models.

37. De Novo Pyrimidine Synthesis is a Targetable Vulnerability in IDH Mutant Glioma

38. Multimodal platform for assessing drug distribution and response in clinical trials

42. Heterogeneous delivery across the blood-brain barrier limits the efficacy of an EGFR-targeting antibody drug conjugate in glioblastoma

43. β-Cyclodextrin-poly (β-Amino Ester) Nanoparticles Are a Generalizable Strategy for High Loading and Sustained Release of HDAC Inhibitors

44. Blood–brain-barrier organoids for investigating the permeability of CNS therapeutics

45. DDRE-32. THERAPEUTIC TARGETING OF A NOVEL METABOLIC ADDICTION IN DIFFUSE MIDLINE GLIOMA

47. CTNI-25. PHASE IB CLINICAL TRIAL OF CHRONIC CONVECTION-ENHANCED DELIVERY OF TOPOTECAN FOR RECURRENT GLIOBLASTOMA

48. TAMI-45. PHENOGENOMIC CHARACTERIZATION OF IMMUNOMODULATORY PURINERGIC SIGNALING IN GLIOBLASTOMA

49. Translational Breast Cancer Research Consortium 022: Pre- and Post-operative Neratinib for HER2-positive Breast Cancer Brain Metastases

50. Integrated mapping of pharmacokinetics and pharmacodynamics in a patient-derived xenograft model of glioblastoma

Catalog

Books, media, physical & digital resources